Synthesis 2012; 44(21): 3392-3398
DOI: 10.1055/s-0032-1316777
paper
© Georg Thieme Verlag Stuttgart · New York

Functionalization of Chromones through an Aza-Baylis–Hillman-Type Reaction

Michael A. Terzidis
a   Department of Chemistry, Laboratory of Organic Chemistry, University of Thessaloniki, 54124 Macedonia, Greece
,
Vassilios G. Tsiaras
a   Department of Chemistry, Laboratory of Organic Chemistry, University of Thessaloniki, 54124 Macedonia, Greece
,
Julia Stephanidou-Stephanatou*
a   Department of Chemistry, Laboratory of Organic Chemistry, University of Thessaloniki, 54124 Macedonia, Greece
,
Constantinos A. Tsoleridis*
a   Department of Chemistry, Laboratory of Organic Chemistry, University of Thessaloniki, 54124 Macedonia, Greece
,
Vassilis Psycharis
b   Institute of Materials Science, NCSR Demokritos, 15310 Aghia Paraskevi Attikis, Greece   Fax: +30(2310)997679   Email: ioulia@chem.auth.gr   Email: tsolerid@chem.auth.gr
,
Catherine P. Raptopoulou
b   Institute of Materials Science, NCSR Demokritos, 15310 Aghia Paraskevi Attikis, Greece   Fax: +30(2310)997679   Email: ioulia@chem.auth.gr   Email: tsolerid@chem.auth.gr
› Author Affiliations
Further Information

Publication History

Received: 17 July 2012

Accepted after revision: 22 August 2012

Publication Date:
17 September 2012 (online)


Abstract

The synthesis of (N,N′-bisalkoxycarbonyl)hydrazinochromones via the aza-Baylis–Hillman reaction of formylchromones and azodicarboxylates is reported. A plausible mechanistic scheme for the formation of these compounds, involving the chromone formyl group elimination, is proposed. Conformational analysis was performed by DFT calculations. The structure of one example was confirmed by XRD investigation. Full assignment of all 1H and 13C NMR chemical shifts has been unambiguously achieved.

Supporting Information

 
  • References

    • 1a Yang Y, Xu Y, Xia T, Chen F, Zhang C, Liang W, Lai L, Fang X. Chem. Commun. 2011; 47: 5440
    • 1b Hyz K, Kawecki R, Misior A, Bocian W, Bednarek E, Sitkowski J, Kozerski L. J. Med. Chem. 2011; 54: 8386
    • 1c Gobbi S, Cavalli A, Rampa A, Belluti F, Piazzi L, Paluszcak A, Hartmann RW, Recanatini M, Bisi A. J. Med. Chem. 2006; 49: 4777
    • 1d Nutley BP, Smith NF, Hayes A, Kelland LR, Brunton L, Golding BT, Smith GC. M, Martin NM. B, Workman P, Raynaud FI. Br. J. Cancer 2005; 93: 1011
    • 1e Boumendjel A, Nicolle E, Moraux T, Gerby B, Blanc M, Ronot X, Boutonnat J. J. Med. Chem. 2005; 48: 7275
    • 1f Ahmed-Belkacem A, Pozza A, Muñoz-Martínez F, Bates SE, Castanys S, Gamarro F, Di Pietro A, Pérez-Victoria JM. Cancer Res. 2005; 65: 4852
    • 1g Morris J, Wishka DG, Lin AH, Humphrey WR, Wiltse AL, Gammill RB, Judge TM, Bisaha SN, Olds NL, Jacob CS, Bergh CL, Cudahy MM, Williams DJ, Nishizawa EE, Thomas EW, Gorman RR, Benjamin CW, Shebuski RJ. J. Med. Chem. 1993; 36: 2026
    • 1h Horie T, Tominaga H, Kawamura Y, Hada T, Ueda N, Amano Y, Yamamoto S. J. Med. Chem. 1991; 34: 2169
    • 2a Vedachalam S, Zeng J, Gorityala BK, Antonio M, Liu X.-W. Org. Lett. 2010; 12: 352
    • 2b Dauzonne D, Folléas B, Martinez L, Chabot GG. Eur. J. Med. Chem. 1997; 32: 71
    • 3a Sawada T, Hashimoto S, Tohma S, Nishioka Y, Nagai T, Sato T, Ito K, Inoue T, Iwata M, Yamamoto K. Immunopharmacology 2000; 49: 285
    • 3b Inaba T, Tanaka K, Takeno R, Nagaki H, Yoshida C, Takano S. Chem. Pharm. Bull. 2000; 48: 131
    • 4a Tanaka K, Yamamoto T, Aikawa Y, Kizawa K, Muramoto K, Matsuno H, Muraguchi A. Rheumatology 2003; 42: 1365
    • 4b Kuriyama K, Higuchi C, Tanaka K, Yoshikawa H, Itoh K. Biochem. Biophys. Res. Commun. 2002; 299: 903
    • 4c Aikawa Y, Yamamoto M, Yamamoto T, Morimoto K, Tanaka K. Inflamm. Res. 2002; 51: 188
    • 4d Kawakami A, Tsuboi M, Urayama S, Matsuoka N, Yamasaki S, Hida A, Aoyagi T, Furuichi I, Nakashima T, Migita K, Kawabe Y, Nakashima M, Origuchi T, Eguchi K. J. Lab. Clin. Med. 1999; 133: 566
    • 4e Aikawa Y, Tanuma N, Shin T, Makino S, Tanaka K, Matsumoto Y. J. Neuroimmunol. 1998; 89: 35
  • 5 Quiney C, Dauzonne D, Kern C, Fourneron J.-D, Izard J.-C, Mohammad RM, Kolb J.-P, Billard C. Leukemia Res. 2004; 28: 851
  • 6 Beudot C, De Méo MP, Dauzonne D, Elias R, Laget M, Guiraud H, Balansard G, Duménil G. Mutat. Res. 1998; 417: 141
  • 7 Geissler JF, Roesel JL, Meyer T, Trinks UP, Traxler P, Lydon NB. Cancer Res. 1992; 52: 4492
    • 8a Fridén-Saxin M, Pemberton N, Da Silva Andersson K, Dyrager C, Friberg A, Grøtli M, Luthman K. J. Org. Chem. 2009; 74: 2755
    • 8b Bauvois B, Puiffe M.-L, Bongui J.-B, Paillat S, Monneret C, Dauzonne D. J. Med. Chem. 2003; 46: 3900
    • 8c DeWald HA, Heffner TG, Jaen JC, Lustgarten DM, McPhail AT, Meltzer LT, Pugsley TA, Wise LD. J. Med. Chem. 1990; 33: 445
    • 9a Declerck V, Martinez J, Lamaty F. Chem. Rev. 2009; 109: 1
    • 9b Nair V, Biju AT, Mathew SC, Babu BP. Chem.–Asian J. 2008; 3: 810
    • 9c Shi M, Zhao G.-L. Tetrahedron 2004; 60: 2083
    • 9d Kamimura A, Gunjigake Y, Mitsudera H, Yokoyama S. Tetrahedron Lett. 1998; 39: 7323
    • 10a Basavaiah D, Rao AJ, Satyanarayana T. Chem. Rev. 2003; 103: 811
    • 10b Shi Y.-L, Shi M. Synlett 2005; 2623
    • 10c Shi Y.-L, Shi M. Eur. J. Org. Chem. 2007; 2905
    • 10d Shi Y.-L, Shi M. Org. Biomol. Chem. 2007; 1499
    • 10e Singh V, Batra S. Tetrahedron 2008; 64: 4511
    • 11a Basavaiah D, Rao AJ. Tetrahedron Lett. 2003; 44: 4365
    • 11b Molefe DM, Kaye PT. Synth. Commun. 2009; 39: 3586
  • 12 Wu C, Liu Y, Zeng H, Liu L, Wang D, Chen Y. Org. Biomol. Chem. 2011; 9: 253
    • 13a Terzidis M, Tsoleridis CA, Stephanidou-Stephanatou J. Tetrahedron Lett. 2005; 46: 7239
    • 13b Terzidis M, Tsoleridis CA, Stephanidou-Stephanatou J. Tetrahedron 2007; 63: 7828
    • 13c Zarganes-Tzitzikas T, Terzidis MA, Tsoleridis CA, Stephanidou-Stephanatou J. J. Org. Chem. 2011; 76: 9008
    • 14a Terzidis MA, Stephanidou-Stephanatou J, Tsoleridis CA. Tetrahedron Lett. 2009; 50: 1196
    • 14b Terzidis MA, Stephanidou-Stephanatou J, Tsoleridis CA, Terzis A, Raptopoulou CP, Psycharis V. Tetrahedron 2010; 66: 947
    • 14c Terzidis MA, Tsoleridis CA, Stephanidou-Stephanatou J. J. Org. Chem. 2010; 75: 1948
    • 14d Terzidis MA, Tsiaras VG, Stephanidou-Stephanatou J, Tsoleridis CA. Synthesis 2011; 97
  • 15 Papafilippou A, Terzidis MA, Stephanidou-Stephanatou J, Tsoleridis CA. Tetrahedron Lett. 2011; 52: 1306
  • 16 Terzidis MA, Tsoleridis CA, Stephanidou-Stephanatou J, Terzis A, Raptopoulou CP, Psycharis V. Tetrahedron 2008; 64: 11611
  • 17 Complete crystallographic data for compound 3a have been deposited with the Cambridge Crystallographic Data Centre as supplementary publication No. CCDC 882016. Copies of the data can be obtained free of charge on application to CCDC, 12 Union Road, Cambridge CB2 1EZ, UK; fax: +44(1223)336 033, e-mail: deposit@ccdc.cam.ac.uk
  • 18 Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Montgomery JA. Jr, Vreven T, Kudin KN, Burant JC, Millam JM, Iyengar SS, Tomasi J, Barone V, Mennucci B, Cossi M, Scalmani G, Rega N, Petersson GA, Nakatsuji H, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Klene M, Li X, Knox JE, Hratchian HP, Cross JB, Bakken V, Adamo C, Jaramillo J, Gomperts R, Stratmann RE, Yazyev O, Austin AJ, Cammi R, Pomelli C, Ochterski JW, Ayala PY, Morokuma K, Voth GA, Salvador P, Dannenberg JJ, Zakrzewski VG, Dapprich S, Daniels AD, Strain MC, Farkas O, Malick DK, Rabuck AD, Raghavachari K, Foresman JB, Ortiz JV, Cui Q, Baboul AG, Clifford S, Cioslowski J, Stefanov BB, Liu G, Liashenko A, Piskorz P, Komaromi I, Martin RL, Fox DJ, Keith T, Al-Laham MA, Peng CY, Nanayakkara A, Challacombe M, Gill PM. W, Johnson B, Chen W, Wong MW, Gonzalez C, Pople JA. Gaussian03, rev. E.01 11-Sep-2007 . Gaussian, Inc; Wallingford CT: 2004
    • 19a Cancès MT, Mennucci B, Tomasi J. J. Chem. Phys. 1997; 107: 3032
    • 19b Cossi M, Barone V, Mennucci B, Tomasi J. Chem. Phys. Lett. 1998; 286: 253
    • 19c Mennucci B, Tomasi J. J. Chem. Phys. 1996; 106: 5151